Samar F. Ahmed

Safat, KU 13115, Kuwait

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Treatment outcomes of high-efficacy disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: A longitudinal observational study.

Treatment outcomes of high-efficacy disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: A longitudinal observational study.

Journal: Multiple sclerosis and related disorders

Published: August 11, 2025

The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients.

The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: June 19, 2025

Impact of Fingolimod Discontinuation Strategy on Recurrence of Disease Activity in Individuals With Multiple Sclerosis.

Impact of Fingolimod Discontinuation Strategy on Recurrence of Disease Activity in Individuals With Multiple Sclerosis.

Journal: International journal of MS care

Published: November 26, 2024

Efficacy of onabotulinumtoxinA treatment in episodic migraine.

Efficacy of onabotulinumtoxinA treatment in episodic migraine.

Journal: Frontiers in neurology

Published: July 04, 2024

Real-world experiences of migraine patients on Erenumab: a Kuwait single center cohort.

Real-world experiences of migraine patients on Erenumab: a Kuwait single center cohort.

Journal: Neurological research

Published: June 23, 2024

Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study.

Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study.

Journal: Multiple sclerosis and related disorders

Published: May 19, 2024

Pediatric onset multiple sclerosis in Kuwait.

Pediatric onset multiple sclerosis in Kuwait.

Journal: Clinical neurology and neurosurgery

Published: April 04, 2024

Ocrelizumab for pediatric relapsing multiple sclerosis.

Ocrelizumab for pediatric relapsing multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: March 03, 2024

Substantial and comparable suppression of disease activity following early initiation of cladribine tablets, ocrelizumab or alemtuzumab as first pharmacologic treatment for relapsing multiple sclerosis: A real world study.

Substantial and comparable suppression of disease activity following early initiation of cladribine tablets, ocrelizumab or alemtuzumab as first pharmacologic treatment for relapsing multiple sclerosis: A real world study.

Journal: Clinical neurology and neurosurgery

Published: August 02, 2023

Real world study of ocrelizumab in multiple sclerosis: Kuwait experience.

Real world study of ocrelizumab in multiple sclerosis: Kuwait experience.

Journal: Multiple sclerosis and related disorders

Published: June 24, 2023

A real-life study of alemtuzumab in persons with multiple sclerosis: Kuwait's experience.

A real-life study of alemtuzumab in persons with multiple sclerosis: Kuwait's experience.

Journal: Multiple sclerosis and related disorders

Published: November 19, 2022

A prospective observational longitudinal study with a two-year follow-up of multiple sclerosis patients on Cladribine.

A prospective observational longitudinal study with a two-year follow-up of multiple sclerosis patients on Cladribine.

Journal: Clinical neurology and neurosurgery

Published: October 01, 2022

Showing 1-12 of 66

Last Updated: 09/26/2026